NEW STUDIES 1
The Kyolic Garlic & Aerobic Fitness Trial
Arterial stiffness is a cardiovascular risk factor, which increases naturally with age. Kyolic garlic has been shown to improve the flexibility of arteries, and slows down blood flow, which may improve oxygen uptake, associated with aerobic fitness.
NEW STUDIES 2
Update 31 Jan 2023: The outpatient arm of the International ALLIANCE COVID-19 Treatment Study is now closed. Thank you for your interest.
We are currently in the process of analysing the data and publishing our findings of the outpatient Study Arm. Watch this space for any updates.
Link to our Alliance Long Covid Trial: https://niim-rebuild.newpathstudio.com.au/researches/the-alliance-long-covid-19-treatment-trial/
News: 26 Nov 2021 We are pleased to announce that Stage 1 of the International Alliance COVID-19 Treatment Study has now been published:
Ried K, BinJemain T, Sali A (November 25, 2021). Therapies to Prevent Progression of COVID-19, Including Hydroxychloroquine, Azithromycin, Zinc, and Vitamin D3 With or Without Intravenous Vitamin C: An International, Multicenter, Randomized Trial. Cureus 13(11): e19902. link: doi:10.7759/cureus.19902
Abstract
Stage 1 of the study took place in seven participating hospitals in Turkey. A total of 237 hospitalized patients with COVID-19 aged 22-99 years (mean: 63.3 ± 15.7 years) were enrolled in the study. Almost all patients were vitamin D deficient (97%), 55% were severely vitamin D deficient (<25 nmol/L), and 42% were vitamin D deficient (<50 nmol/L); 3% had insufficient vitamin D levels (<75 nmol/L), and none had optimal vitamin D levels.
The study suggests that the treatment protocol of HCQ, AZM, and Zinc with or without vitamin C is safe and effective in the treatment of COVID-19, with high dose IV vitamin C leading to a significantly quicker recovery. The observed fatality rate of 0.4% (1/237) in our study stands in contrast to a 17% fatality rate of hospitalised COVID-19 patients receiving standard care, based on a meta-analysis of 33 international studies involving 13,400 patients.
In summary, the study confirms vitamin D deficiency to be a high-risk factor of severe COVID-19 disease and hospitalization. Furthermore, the study provides evidence for HCQ, AZM, zinc, with or without Intravenous Vitamin C to be a safe and effective in the treatment of COVID-19.
Investigators:
The Trial has ethics and TGA approval and is registered on the ANZ clinical trial registry (www.anzctr.org.au) ACTRN12620000557932.
Therapies to prevent progression of COVID-19 – a multicentre international randomised trial
In-hospital protocol:
Outpatient protocol:
If you don’t have any symptoms of COVID-19, but are interested in the benefits of Vitamin D, you are encouraged to
get your Vitamin D levels measured by your local GP (or via http://imedical.com.au -> private blood test)
To learn more about Vitamin D, visit:
https://niim-rebuild.newpathstudio.com.au/researches/the-vitamin-d-study/
References
NIIM Clinic “Voice of the Patient” Survey
We recently surveyed our patients of the NIIM Clinic to measure their satisfaction with our Practice. With over 200 responses to the Voice of the Patient survey, we received valuable information about what we do well and what we need to work on in order to provide quality services as an accredited medical practice.
What to Expect: Your First Consultation With a NIIM Integrative General Practitioner
An initial consultation with one of our Integrative General Practitioners at NIIM is usually 45 to 60 minutes. These longer consultations are important to thoroughly identify and address the underlying causes of your health issues and start to implement a management plan.
Rife Frequency Study
This study uses Electro-Magnetic-Frequency Therapy (EMF), for the treatment of cancer and/or pathogens, and Circulating Tumour Cell (CTC) blood testing to assess EMF treatment effectiveness.
The Cognitive Preservation Study
This study aims to analyse the effect of Red Light Therapy, with or without additional Hyperbaric Oxygen Therapy, on cognition and brain health in people with mild and moderate cognitive impairment.
The Gluco-Metabolism Study
12-week randomised placebo-controlled trial investigating the tolerability and effectiveness of the Nutrition Care Gluco-Metabolism herbal Formula on blood glucose levels.
